IRIS
BITTONI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.971
EU - Europa 1.655
AS - Asia 1.427
SA - Sud America 360
AF - Africa 131
Continente sconosciuto - Info sul continente non disponibili 93
OC - Oceania 1
Totale 7.638
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.864
SG - Singapore 531
IT - Italia 369
BR - Brasile 293
CN - Cina 267
VN - Vietnam 252
RU - Federazione Russa 237
UA - Ucraina 204
SE - Svezia 168
DE - Germania 160
IE - Irlanda 119
TR - Turchia 105
FI - Finlandia 88
FR - Francia 82
DK - Danimarca 72
HK - Hong Kong 72
GB - Regno Unito 71
CI - Costa d'Avorio 60
IN - India 46
CA - Canada 45
KR - Corea 40
NL - Olanda 34
BD - Bangladesh 29
MA - Marocco 27
MX - Messico 23
JP - Giappone 21
AR - Argentina 18
ZA - Sudafrica 17
EC - Ecuador 15
CO - Colombia 14
IL - Israele 14
ES - Italia 13
PL - Polonia 11
IQ - Iraq 9
BE - Belgio 8
HN - Honduras 8
ID - Indonesia 7
SC - Seychelles 7
DZ - Algeria 6
GT - Guatemala 6
MY - Malesia 6
CL - Cile 5
CR - Costa Rica 5
SV - El Salvador 5
UY - Uruguay 5
VE - Venezuela 5
CZ - Repubblica Ceca 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
EG - Egitto 3
EU - Europa 3
GP - Guadalupe 3
KE - Kenya 3
PH - Filippine 3
PR - Porto Rico 3
RS - Serbia 3
SA - Arabia Saudita 3
TN - Tunisia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AT - Austria 2
BO - Bolivia 2
ET - Etiopia 2
JM - Giamaica 2
LT - Lituania 2
NI - Nicaragua 2
OM - Oman 2
PK - Pakistan 2
PY - Paraguay 2
RO - Romania 2
TW - Taiwan 2
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
MR - Mauritania 1
MT - Malta 1
NG - Nigeria 1
NP - Nepal 1
QA - Qatar 1
TT - Trinidad e Tobago 1
Totale 7.549
Salva come PNG Salva come JPEG
Città #
Ashburn 736
Singapore 331
Chandler 286
Jacksonville 216
Fairfield 210
San Jose 201
Wilmington 135
Dallas 126
Boardman 119
Council Bluffs 118
Dublin 118
New York 117
Woodbridge 103
Ann Arbor 95
Seattle 94
Houston 93
Des Moines 76
Beijing 74
Cambridge 72
Ho Chi Minh City 70
Centro 67
Hanoi 66
Hong Kong 66
Abidjan 60
Los Angeles 58
Princeton 54
Moscow 49
The Dalles 49
Lawrence 47
Munich 47
San Mateo 47
Lauterbourg 37
Turin 37
Turku 33
Milan 28
Orem 27
Santa Clara 27
Buffalo 20
London 20
São Paulo 20
San Diego 19
Tokyo 19
Atlanta 18
Helsinki 17
Chicago 16
Hefei 16
Frankfurt am Main 15
Montreal 15
Amsterdam 14
Chennai 14
Rome 14
Brooklyn 13
Johannesburg 13
Da Nang 12
Stockholm 12
Haiphong 11
Pune 11
Rio de Janeiro 10
Denver 9
Warsaw 9
Brussels 8
Curitiba 8
Guayaquil 8
Phoenix 8
Poplar 8
Brasília 7
Columbus 7
Fortaleza 7
Guangzhou 7
Manchester 7
Mexico City 7
Miano 7
Palermo 7
Paris 7
San Francisco 7
St Petersburg 7
Toronto 7
Washington 7
Wuhan 7
Wuxi 7
Belo Horizonte 6
Biên Hòa 6
Cagliari 6
Miami 6
Porto Alegre 6
Bogotá 5
Florence 5
Guatemala City 5
Montevideo 5
Santiago 5
Bến Tre 4
Charlotte 4
City of London 4
Dhaka 4
Falls Church 4
Izmir 4
Mumbai 4
Nanjing 4
New Bedfont 4
Nuremberg 4
Totale 4.766
Salva come PNG Salva come JPEG
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 229
Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy 215
Impact of polypharmacy for chronic ailments in colon cancer patients: A review focused on drug repurposing. 214
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 207
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 207
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab. 201
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 201
Optimal management of resected gastric cancer 197
Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses 195
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 183
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 178
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia 177
HER family receptor expression and prognosis in pancreatic cancer 175
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 175
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 172
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 170
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma 169
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 167
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 164
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 163
Medical treatment for cholangiocarcinoma 161
Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival 160
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. 159
Panitumumab for the treatment of metastatic colorectal cancer: A review 158
Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target 156
Trattamento del carcinoma del pancreas. Attualità e prospettive 155
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 153
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer 151
ASSOCIAZIONE TRA STATO MUTAZIONALE DI KRAS E PATTERN DI ESPRESSIONE GENETICA NEL CARCINOMA DEL PANCREAS 149
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 148
Doses of capecitabine and oral vinorelbine are not relevant for efficacy in breast cancer patients: an analysis of dose intensity. 147
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 145
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 144
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients. 144
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 143
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 143
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 141
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 141
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 134
Palliative treatment 132
Selecting the best treatment for an individual patient. 130
Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients 127
Yes-associated protein and immunosuppressive microenvironment in pancreatic cancer development: A new strategy to improve immunotherapy efficacy? 126
The challenge of targeted therapies for gastric cancer patients: The beginning of a long journey 122
Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives. 115
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 113
Predictive factors for sunitinib treatment response in advanced renal cell carcinoma: are we really making steps forward? 98
Sicurezza degli ESA: sopravvivenza e stimolazione recettoriale/progressione tumorale 84
Totale 7.638
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.635
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022252 0 0 0 0 5 29 17 23 17 54 29 78
2022/2023854 60 117 59 62 62 141 1 46 193 10 80 23
2023/2024501 74 8 45 61 69 131 5 20 3 8 10 67
2024/2025987 148 77 20 21 64 49 99 35 162 71 133 108
2025/20262.720 209 184 132 309 379 208 417 259 210 232 81 100
2026/2027517 88 75 102 213 39 0 0 0 0 0 0 0
Totale 7.638